Neurobiological Technologies

(OTC) NTII

Current Price$0.00

Market CapN/A

Since IPO (1994)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Neurobiological Technologies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$28.81M

Net Income (TTM)

$11.29M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

578.15 (High)

Dividend

$0.00

Beta (Volatility)

578.15 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

578.15 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

NTII News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neurobiological Technologies

Industry

Biotechnology

Sector

Health Care

Headquarters

EmeryVille, CA 94608, US

NTII Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

13%

Net Income Margin

12%

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

27.02M

Volume

Avg. Volume

768.762

Financials (TTM)

Gross Profit

$26.22M

Operating Income

$3.49M

EBITDA

$3.25M

Operating Cash Flow

$16.43M

Capital Expenditure

$2.00K

Free Cash Flow

$16.43M

Cash & ST Invst.

$2.58M

Total Debt

$0.00

Neurobiological Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2009YOY CHG

Revenue

$6.03M

+69.0%

Gross Profit

$6.03M

+69.0%

Gross Margin

100.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$5.41M

+295.7%

EBITDA

$5.16M

+262.9%

Quarterly Fundamentals

Name

Q1 2009YOY CHG

Net Cash

$26.49M

-6.0%

Accounts Receivable

$3.00M

+1530.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

1.21%

N/A

Return on Invested Capital

1.39%

N/A

Free Cash Flow

$2.36M

+178.2%

Operating Cash Flow

$2.36M

+178.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ANTHAnthera Pharmaceuticals, Inc.

ANTHAnthera Pharmaceuticals, Inc.$0.00+0.00%

GBIMGlobeImmune, Inc.

GBIMGlobeImmune, Inc.$0.00+0.00%

SYVCSynovics Pharmaceuticals, Inc.

SYVCSynovics Pharmaceuticals, Inc.$0.00+0.00%

OVITOncoVista Innovative Therapies, Inc.

OVITOncoVista Innovative Therapies, Inc.$0.00+0.00%

PZRXQPhaseRx, Inc.

PZRXQPhaseRx, Inc.$0.00+0.00%

SNNAQSienna Biopharmaceuticals, Inc.

SNNAQSienna Biopharmaceuticals, Inc.$0.00+0.00%

CMRAComera Life Sciences Holdings, Inc.

CMRAComera Life Sciences Holdings, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ODYSOdysight.ai

ODYSOdysight.ai$9.90+1.22%

NOKNokia

NOKNokia$13.03+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.04%

DGXXDigi Power X

DGXXDigi Power X$7.55+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.48+0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.58+0.00%

INTCIntel

INTCIntel$127.20+0.02%

Questions About NTII

What is the current price of Neurobiological Technologies?

Neurobiological Technologies is trading at N/A per share.

What is the 52-week range for Neurobiological Technologies?

Over the past 52 weeks, Neurobiological Technologies has traded between N/A and $0.00.

How much debt does Neurobiological Technologies have?

Neurobiological Technologies total debt is unavailable.

How much cash does Neurobiological Technologies have on hand?

Neurobiological Technologies does not have cash on hand data available.

What is Neurobiological Technologies’s dividend yield?

Neurobiological Technologies does not currently have a dividend yield.

Neurobiological Technologies

Neurobiological Technologies Financials at a Glance

NTII News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Neurobiological Technologies

NTII Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Neurobiological Technologies Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NTII

What is the current price of Neurobiological Technologies?

What is the 52-week range for Neurobiological Technologies?

How much debt does Neurobiological Technologies have?

How much cash does Neurobiological Technologies have on hand?

What is Neurobiological Technologies’s dividend yield?

Premium Investing Services